136 related articles for article (PubMed ID: 10597254)
1. Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line.
Ma L; Gauvillé C; Berthois Y; Millot G; Johnson GR; Calvo F
Oncogene; 1999 Nov; 18(47):6513-20. PubMed ID: 10597254
[TBL] [Abstract][Full Text] [Related]
2. [Amphiregulin antisense RNA expression inhibits angiogenesis of human breast cancer in nude mice].
Ma L; Serova M; Podgorniak MP; Berthois Y; Mourah S; Calvo F
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):521-3. PubMed ID: 16438846
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells.
Silvy M; Giusti C; Martin PM; Berthois Y
Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474
[TBL] [Abstract][Full Text] [Related]
4. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
Castillo J; Erroba E; Perugorría MJ; Santamaría M; Lee DC; Prieto J; Avila MA; Berasain C
Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186
[TBL] [Abstract][Full Text] [Related]
6. Antisense inhibition of amphiregulin expression reduces EGFR phosphorylation in transformed human breast epithelial cells.
Ma L; Huet E; Serova M; Berthois Y; Calvo F; Mourah S; Menashi S
Anticancer Res; 2010 Jun; 30(6):2101-6. PubMed ID: 20651357
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
8. Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells.
Li S; Plowman GD; Buckley SD; Shipley GD
J Cell Physiol; 1992 Oct; 153(1):103-11. PubMed ID: 1522124
[TBL] [Abstract][Full Text] [Related]
9. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
10. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
[TBL] [Abstract][Full Text] [Related]
11. Expression of amphiregulin in human gastric cancer cell lines.
Akagi M; Yokozaki H; Kitadai Y; Ito R; Yasui W; Haruma K; Kajiyama G; Tahara E
Cancer; 1995 Mar; 75(6 Suppl):1460-6. PubMed ID: 7889475
[TBL] [Abstract][Full Text] [Related]
12. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
13. Antisense epidermal growth factor receptor (EGFR) transfection down-regulates EGFR expression and suppresses the malignant phenotype of human nasopharyngeal carcinoma CNE-2 cell line.
Deng F; Wang Y; Zeng FY; Zou ZP; Bai XC; Lu D; Ke ZY; Luo SQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):877-81. PubMed ID: 13129707
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
15. Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells.
Menashi S; Serova M; Ma L; Vignot S; Mourah S; Calvo F
Cancer Res; 2003 Nov; 63(22):7575-80. PubMed ID: 14633669
[TBL] [Abstract][Full Text] [Related]
16. Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells.
Ma L; Gauvillé C; Berthois Y; Degeorges A; Millot G; Martin PM; Calvo F
Int J Cancer; 1998 Sep; 78(1):112-9. PubMed ID: 9724102
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
[TBL] [Abstract][Full Text] [Related]
18. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells.
Su L; Mukherjee AB; Mukherjee BB
Oncogene; 1995 Jun; 10(11):2163-9. PubMed ID: 7784060
[TBL] [Abstract][Full Text] [Related]
19. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
[TBL] [Abstract][Full Text] [Related]
20. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
